Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial

Published:2010-05-24 Issue:6 Volume:12 Page:607-616
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Castagno Davide¹²,Jhund Pardeep S.²,McMurray John J.V.²,Lewsey James D.³,Erdmann Erland⁴,Zannad Faiez⁵,Remme Willem J.⁶,Lopez-Sendon José L.⁷,Lechat Philippe⁸,Follath Ferenc⁹,Höglund Christer¹⁰,Mareev Viacheslav¹¹,Sadowski Zygmunt¹²,Seabra-Gomes Ricardo J.¹³,Dargie Henry J.¹⁴

Affiliation:

1. Cardiology Unit, Department of Internal Medicine; University of Turin; Turin Italy

2. BHF Glasgow Cardiovascular Research Centre, Faculty of Medicine; University of Glasgow; Glasgow G12 8TA UK

3. Department of Public Health, Faculty of Medicine; University of Glasgow; Glasgow UK

4. Department III of Internal Medicine; University of Cologne; Cologne Germany

5. Inserm, CIC9501, U961, CHU and University of Nancy; Nancy France

6. Sticares Cardiovascular Research Institute; Rhoon Netherlands

7. Department of Cardiology; University Hospital La Paz; Madrid Spain

8. Pharmacology Department; Pitié-Salpêtrière Hospital, APHP, UPMC; Paris

9. University Hospital Zürich; Zürich Switzerland

10. City Heart; Stockholm Sweden

11. Myasnikow Institute of Cardiology; Moscow Russia

12. National Institute of Cardiology; Warsaw Poland

13. Cardiology Department; Santa Cruz Hospital; Carnaxide Portugal

14. Western Infirmary; Glasgow UK

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. Renal function, neurohormonal activation, and survival in patients with chronic heart failure;Hillege;Circulation,2000

2. Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival;Smilde;Am Heart J,2004

3. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction. The Survival And Ventricular Enlargement (SAVE) study;Tokmakova;Circulation,2004

4. Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial;Shlipak;J Am Soc Nephrol,2004

5. Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine. Consistency across subgroups in the African-American Heart Failure Trial;Taylor;Circulation,2007

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Looking for the ideal medication for heart failure with reduced ejection fraction: a narrative review;Frontiers in Cardiovascular Medicine;2024-09-06

2. Management of patients with heart failure and chronic kidney disease;Heart Failure Reviews;2024-07-29

3. An Updated Review of the Management of Chronic Heart Failure in Patients with Chronic Kidney Disease;Reviews in Cardiovascular Medicine;2024-04-11

4. What to do with foundation therapies for heart failure for patients with end-stage kidney disease on haemodialysis;British Journal of Hospital Medicine;2024-04-02

5. Heart failure management with β-blockers: can we do better?;Current Medical Research and Opinion;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3